4.4 Article

MiR-199a-5p promotes migration and tube formation of human cytomegalovirus-infected endothelial cells through downregulation of SIRT1 and eNOS

期刊

ARCHIVES OF VIROLOGY
卷 158, 期 12, 页码 2443-2452

出版社

SPRINGER WIEN
DOI: 10.1007/s00705-013-1744-1

关键词

-

类别

资金

  1. Beijing Natural Science Foundation [7102040, 7132060]
  2. National Natural Science Foundation of China [81041020, 81271311, 81241039]
  3. Traditional Chinese Medicine
  4. Beijing Technology Development Fund [SF2007-III-22]
  5. Beijing Excellent Talent Foundation [20071-D0300100062]
  6. High-Level Technical Training Project Funding of Beijing Health System [2011-3-004]
  7. Beijing City Staff

向作者/读者索取更多资源

Human cytomegalovirus (HCMV) infection has been shown to contribute to vascular disease through the induction of angiogenesis. However, the role of microRNA in angiogenesis induced by HCMV infection remains unclear. The present study was thus designed to explore the potential effect of miR-199a-5p on angiogenesis and to investigate the underlying mechanism in endothelial cells. We found that HCMV infection of endothelial cells (ECs) enhanced expression of miR-199a-5p and reduced the SIRT1 protein level at 24 h postinfection (hpi). Transfection with miR-199a-5p mimics significantly suppressed SIRT1 protein expression and promoted cellular migration and tube formation induced by HCMV infection, which could be reversed by transfection with an miR-199a-5p inhibitor. Furthermore, pretreatment with resveratrol depressed motility and tube formation of HCMV-infected ECs, which could be reversed by SIRT1 siRNA. Finally, overexpression of miR-199a-5p decreased the level of eNOS modulated by SIRT1, an effect repressed by transfection with an miR-199a-5p inhibitor. In summary, HCMV infection of endothelial cells upregulates miR-199a-5p expression and enhances cell migration and tube formation through downregulation of SIRT1/eNOS by miR-199a-5p.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据